Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

160.17
+0.53000.33%
Post-market: 156.10-4.0700-2.54%19:59 EDT
Volume:2.23M
Turnover:356.02M
Market Cap:248.42B
PE:23.98
High:161.51
Open:161.43
Low:158.13
Close:159.64
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.64
T/O Rate:0.15%
Dividend:3.16
Dividend Rate:1.97%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.94
PE(LYR):24.49

Loading ...

Jefferies Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 07

AstraZeneca Scores Minor Positive with U.S. Approval for Breast-Cancer Drug

Dow Jones
·
Sep 07

Citi Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 07

AstraZeneca Gets FDA Approval for Breast Cancer Treatment

Dow Jones
·
Sep 05

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 05

Alnylam's Zilebesiran Sees Commercial Opportunity From Baxfendy Launch, Oppenheimer Says

MT Newswires Live
·
Sep 04

AstraZeneca's New Lung Treatment Could Become Market Leader

Dow Jones
·
Sep 03

Berenberg Bank Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 03

AstraZeneca PLC Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 03

Deutsche Bank Sticks to Its Sell Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

AstraZeneca completes global license agreement for Zegfrovy in lung cancer

TIPRANKS
·
Sep 01

AstraZeneca Reports 'Meaningful Improvement' in Phase 3 Study of Lung Cancer Patients

MT Newswires Live
·
Sep 01

AstraZeneca Says Breast Cancer Combo Approved in EU; Completes Acquisition of License for Lung Cancer Treatment

MT Newswires Live
·
Sep 01

Movement Alert|AstraZeneca PLC Declines 4.14% Overnight, Competitive Threat From Summit Ivosdenib Data Weighs on Immuno-Oncology Outlook

Market Focus
·
Sep 01

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 01

Hutchmed Says Lung Cancer Therapy Improves Progression-Free Survival in China Phase 3 Trial

MT Newswires Live
·
Aug 31

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 29

Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data

TIPRANKS
·
Aug 28

AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial

TIPRANKS
·
Aug 28